MoneyWorks4Me

Norris Medicines - Quaterly Results

14 Aug 2025 Evaluate
The total revenue for the June 2025 quarter zoomed 100.97% to Rs. 14.57 millions as compared to Rs. 7.25 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -3.12 millions as compared to Net Loss of Rs. -3.66 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to -0.77% as compared to -1.50% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 14.57 7.25 100.97 14.57 7.25 100.97 58.20 56.36 3.26
Other Income 0.24 0.12 100.00 0.24 0.12 100.00 0.61 0.28 117.86
PBIDT -0.77 -1.50 -48.67 -0.77 -1.50 -48.67 -2.01 -1.57 28.03
Interest 1.12 0.84 33.33 1.12 0.84 33.33 4.40 3.70 18.92
PBDT -1.89 -2.34 -19.23 -1.89 -2.34 -19.23 -6.41 -5.27 21.63
Depreciation 1.23 1.32 -6.82 1.23 1.32 -6.82 5.37 5.72 -6.12
PBT -3.12 -3.66 -14.75 -3.12 -3.66 -14.75 -11.78 -10.99 7.19
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.59 0.89 -33.71
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.59 0.89 -33.71
PAT -3.12 -3.66 -14.75 -3.12 -3.66 -14.75 -12.37 -11.88 4.12
Equity 99.26 99.26 0.00 99.26 99.26 0.00 99.26 99.26 0.00
PBIDTM(%) -5.28 -20.69 -74.46 -5.28 -20.69 -74.46 -3.45 -2.79 23.98
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..